Literature DB >> 34037917

Development of a preference-based heart disease-specific health state classification system using MacNew heart disease-related quality of life instrument.

Sanjeewa Kularatna1, Donna Rowen2, Clara Mukuria2, Steven McPhail3,4, Gang Chen5, Brendan Mulhern6, Jennifer A Whitty7,8, Joshua Byrnes9, Paul Scuffham9, John Atherton10, Stefan Höfer11, William Parsonage3,10.   

Abstract

PURPOSE: The MacNew Heart Disease Health-Related Quality of Life Instrument (MacNew) is a validated, clinically sensitive, 27-item disease-specific questionnaire. This study aimed to develop a new heart disease-specific classification system for the MacNew amenable for use in health state valuation.
METHODS: Patients with heart disease attending outpatient clinics and inpatient wards in Brisbane, Australia, completed MacNew. The development of the new disease-specific classification system included three stages. First, a principal component analysis (PCA) established dimensionality. Second, Rasch analysis was used to select items for each dimension. Third, Rasch analysis was used to explore response-level reduction. In addition, clinician and patient judgement informed item selection.
RESULTS: Participants included 685 patients (acute coronary 6%, stable coronary 41%, chronic heart failure 20%). The PCA identified 4 dimensions (restriction, emotion, perception of others, and symptoms). The restriction dimension was divided into physical and social dimensions. One item was selected from each to be included in the classification system. Three items from the emotional dimension and two symptom items were also selected. The final classification system had seven dimensions with four severity levels in each: physical restriction; excluded from doing things with other people; worn out or low in energy; frustrated, impatient or angry; unsure and lacking in self-confidence; shortness of breath; and chest pain.
CONCLUSION: This study generated a brief heart disease-specific classification system, consisting of seven dimensions with four severity levels in each. The classification system is amenable to valuation to enable the generation of utility value sets to be developed for use in economic evaluation.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Year:  2021        PMID: 34037917     DOI: 10.1007/s11136-021-02884-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  28 in total

1.  Valuing the AD-5D Dementia Utility Instrument: An Estimation of a General Population Tariff.

Authors:  Tracy A Comans; Kim-Huong Nguyen; Julie Ratcliffe; Donna Rowen; Brendan Mulhern
Journal:  Pharmacoeconomics       Date:  2020-08       Impact factor: 4.981

2.  Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions.

Authors:  Sanjeewa Kularatna; Joshua Byrnes; Yih Kai Chan; Melinda J Carrington; Simon Stewart; Paul A Scuffham
Journal:  Int J Cardiol       Date:  2016-11-09       Impact factor: 4.164

3.  Valuing EQ-5D health states for Sri Lanka.

Authors:  Sanjeewa Kularatna; Jennifer A Whitty; Newell W Johnson; Ruwan Jayasinghe; Paul A Scuffham
Journal:  Qual Life Res       Date:  2014-12-28       Impact factor: 4.147

4.  Deriving health utilities from the MacNew Heart Disease Quality of Life Questionnaire.

Authors:  Gang Chen; John McKie; Munir A Khan; Jeff R Richardson
Journal:  Eur J Cardiovasc Nurs       Date:  2014-05-14       Impact factor: 3.908

5.  Assessing responsiveness of generic and specific health related quality of life measures in heart failure.

Authors:  Dean T Eurich; Jeffrey A Johnson; Kimberly J Reid; John A Spertus
Journal:  Health Qual Life Outcomes       Date:  2006-11-24       Impact factor: 3.186

Review 6.  EQ-5D and the EuroQol Group: Past, Present and Future.

Authors:  Nancy J Devlin; Richard Brooks
Journal:  Appl Health Econ Health Policy       Date:  2017-04       Impact factor: 2.561

7.  Condition-specific or generic preference-based measures in oncology? A comparison of the EORTC-8D and the EQ-5D-3L.

Authors:  Paula K Lorgelly; Brett Doble; Donna Rowen; John Brazier
Journal:  Qual Life Res       Date:  2016-11-09       Impact factor: 4.147

Review 8.  Valuing health-related quality of life in heart failure: a systematic review of methods to derive quality-adjusted life years (QALYs) in trial-based cost-utility analyses.

Authors:  Jenny Rankin; Donna Rowen; Amanda Howe; John G F Cleland; Jennifer A Whitty
Journal:  Heart Fail Rev       Date:  2019-07       Impact factor: 4.214

9.  Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure.

Authors:  Sanjeewa Kularatna; Sameera Senanayake; Gang Chen; William Parsonage
Journal:  Health Qual Life Outcomes       Date:  2020-04-29       Impact factor: 3.186

10.  Current and projected burden of heart failure in the Australian adult population: a substantive but still ill-defined major health issue.

Authors:  Yih-Kai Chan; Camilla Tuttle; Jocasta Ball; Tiew-Hwa Katherine Teng; Yasmin Ahamed; Melinda Jane Carrington; Simon Stewart
Journal:  BMC Health Serv Res       Date:  2016-09-21       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.